Page 20 - manuscript_ijb05596
P. 20

and high catalytic efficiency, to covalently cross-link gel with recombinant human type

                   III  collagen  (rhCol  III).  This  enzymatic  approach  facilitated  the  formation  of  ε-(γ-

                   glutamyl)lysine  isopeptide  bonds  between  protein  molecules  under  mild  reaction
                   conditions,  thereby  circumventing  the  cytotoxicity  associated  with  chemical  cross-

                   linking agents. Meanwhile, this approach preserved both the biocompatibility and 3D

                   printability,  offering  an  efficient  strategy  for  fabricating  whole-protein  hydrogel

                   scaffolds  with  excellent  mechanical  stability  and  cell-adhesive  properties.  Amin

                                 57
                   Shavandi et al.  fabricated a biocompatible Gel-COS hydrogels through a dual cross-
                   linking  strategy,  including  co-enzyme-mediated  cross-linking  via  Gox/HRP  and

                   phenolized  polyelectrolyte  complex  (PHEC).  The  cross-linking  was  initiated  by

                   spontaneous  electrostatic  interaction  between  positively  charged  CS  and  COS  of

                   negatively charged alginate, followed by mild co-enzymatic cross-linking triggered by

                   H2O2  gradually  released  from  the  GOx  reaction.  This  hydrogel  provided  a  novel

                   therapeutic option for treating disabling diabetic foot and venous leg ulcers through its
                                                                                                    58
                   combined  protective,  healing,  and  antimicrobial  properties.  Lay  Poh  Tan  et  al.

                   developed  a  3D  printed  GelMA  hydrogel  with  adjustable  flow  properties,  shear-
                   thinning  behavior,  and  dual-stage  cross-linking  that  maintained  cell  viability  while

                   producing long-lasting structures for tissue engineering applications.



























                   Figure  4.  Schematic  process  of  the  biocatalytic  mesoporous  silica  nanocomposite  hydrogels.
                   Adapted from  [54] .


                                                            19
   15   16   17   18   19   20   21   22   23   24   25